1613 related articles for article (PubMed ID: 16612774)
1. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
3. Early-stage adenocarcinoma in Barrett's esophagus: aspects of surgical therapies.
Horváth OP; Kalmár K
Dig Dis; 2009; 27(1):45-53. PubMed ID: 19439960
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
5. [Distal esophageal resection and jejunum interposition for early Barrett carcinoma].
Stein HJ; Feith M; Siewert JR
Zentralbl Chir; 2001; 126 Suppl 1():9-13. PubMed ID: 11819163
[TBL] [Abstract][Full Text] [Related]
6. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
7. Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus.
Stein HJ; Hutter J; Feith M; von Rahden BH
Semin Thorac Cardiovasc Surg; 2007; 19(1):72-8. PubMed ID: 17403461
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
[TBL] [Abstract][Full Text] [Related]
9. Surgical strategies for early esophageal adenocarcinoma.
Stein HJ; Feith M
Best Pract Res Clin Gastroenterol; 2005 Dec; 19(6):927-40. PubMed ID: 16338650
[TBL] [Abstract][Full Text] [Related]
10. [Endoscopic mucosal resection of premalignant lesions of the upper gastrointestinal tract].
Wehrmann T; Lange P; Nakamura M; Riphaus A; Stergiou N
Z Gastroenterol; 2001 Nov; 39(11):919-28. PubMed ID: 11778151
[TBL] [Abstract][Full Text] [Related]
11. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
Gilbert S; Jobe BA
Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
14. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
15. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Resecting or burning: what should we do with the remaining barrett's epithelium after successful ER of neoplasia?
Pech O; Ell C
Am J Gastroenterol; 2009 Nov; 104(11):2693-4. PubMed ID: 19888235
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
18. Surgery for early stage esophageal adenocarcinoma.
Stein HJ; von Rahden BH; Feith M
J Surg Oncol; 2005 Dec; 92(3):210-7. PubMed ID: 16299789
[TBL] [Abstract][Full Text] [Related]
19. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
[TBL] [Abstract][Full Text] [Related]
20. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
